WebMar 8, 2024 · The complex pathophysiology of heart failure with preserved ejection fraction (HFpEF) makes it a diagnostic and therapeutic challenge. ... but there is no clinical trial evidence to support its use at the higher range of the LVEF spectrum. 1 In an individual patient-level meta-analysis of double-blind randomized trials, ... WebRehabilitation Enablement in Chronic Heart Failure – a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial. BMJ Open, 2016. Read the full rationale and protocol here. 2015
Denervation or stimulation? Role of sympatho-vagal imbalance in HFpEF …
WebCurrent active members - Rehabilitation Enablement in Chronic Heart Failure REACH-HF Current active members Dr Hayes Dalal Prof Rod Taylor Prof Colin Greaves Prof Patrick Doherty Dr Samantha van Beurden Dr Sinead McDonagh Dr Rosina Cross Pam Baxter Tori Hammond Elena Fantozzi Dr Alan McLeod Miriam Noonan WebNov 9, 2024 · REACH-HF trial co-chief investigator, Professor Rod Taylor from the University of Glasgow’s Institute of Health & Wellbeing, said, “We are delighted to have received this … hillview cemetery newman ca
A randomised controlled trial of a facilitated home-based ...
WebApr 9, 2024 · In uncertain cases, i.e. in patients with a high pre-test probability, exercise intolerance and inconclusive results, an invasive study might be recommended. 15, 20 … WebBackground: Whilst heart failure (HF) with preserved ejection fraction (HFpEF) affects almost 50 percent of the HF population, evidence-based treatment options remain limited. However, there is growing evidence of the potential … WebMay 17, 2024 · VITALITY-HFpEF is a placebo-controlled, double-blind, multi-center, phase IIb trial of ≈735 patients, ≥45 years with HFpEF and ejection fraction ≥45% who will be randomized 1:1:1 to placebo, 10 mg, or 15 mg vericiguat. The primary end point is change in Kansas City Cardiomyopathy Questionnaire physical limitation score from baseline to ... smart network tester